Peptamen® AF (n = 46) | Isosource® Energy (n = 44) | Treatment effect | p value | |||
---|---|---|---|---|---|---|
n | Median (IQR) | n | Median (IQR) | Median differencea (95% CI) | ||
Serum albumin at baseline | 39 | 21.0 (17.0–25.0) | 42 | 21.3 (18.0–24.0) | 0.0 (−2.0 to 2.0) | 0.93 |
Serum albumin at treatment end or at ICU discharge | 17 | 21.0 (19.0–26.0) | 19 | 23.0 (18.0–26.0) | 0.00 (−3.00 to 3.00) | 0.99 |
n | No. of events (pd) | n | No. of events (pd) | Rate ratio (95% CI) | ||
Number of events outside the 4.5–10 mmol/l glycemic range | 46 | 425 (253 pd) | 44 | 582 (287 pd) | 0.83 (0.54–1.28) | 0.39 |